LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,175,269 | -16.3% | 219,881 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $15,739,791 | +5.6% | 218,305 | +7.8% | 0.00% | 0.0% |
| Q1 2023 | $14,902,595 | +9.7% | 202,591 | -0.3% | 0.00% | 0.0% |
| Q4 2022 | $13,578,904 | -8.9% | 203,277 | +17.4% | 0.00% | 0.0% |
| Q3 2022 | $14,906,000 | -15.3% | 173,113 | -12.2% | 0.00% | -25.0% |
| Q2 2022 | $17,597,000 | -22.6% | 197,221 | -2.5% | 0.00% | 0.0% |
| Q1 2022 | $22,746,000 | -37.7% | 202,214 | -14.4% | 0.00% | -33.3% |
| Q4 2021 | $36,499,000 | +9.7% | 236,304 | -1.0% | 0.01% | 0.0% |
| Q3 2021 | $33,269,000 | -11.2% | 238,790 | -16.4% | 0.01% | -14.3% |
| Q2 2021 | $37,456,000 | +4.5% | 285,505 | +21.5% | 0.01% | 0.0% |
| Q1 2021 | $35,834,000 | +48.3% | 235,055 | -3.3% | 0.01% | +40.0% |
| Q4 2020 | $24,162,000 | -5.2% | 242,957 | -9.1% | 0.01% | -16.7% |
| Q3 2020 | $25,483,000 | -23.5% | 267,353 | -10.2% | 0.01% | -25.0% |
| Q2 2020 | $33,315,000 | +54.4% | 297,852 | +0.4% | 0.01% | +33.3% |
| Q1 2020 | $21,577,000 | -31.9% | 296,711 | -2.4% | 0.01% | -14.3% |
| Q4 2019 | $31,699,000 | -4.5% | 303,962 | -8.9% | 0.01% | -12.5% |
| Q3 2019 | $33,203,000 | -17.7% | 333,566 | -5.6% | 0.01% | -20.0% |
| Q2 2019 | $40,345,000 | -14.5% | 353,440 | -5.9% | 0.01% | -16.7% |
| Q1 2019 | $47,209,000 | -4.5% | 375,542 | +3.1% | 0.01% | -14.3% |
| Q4 2018 | $49,450,000 | -42.5% | 364,412 | +16.2% | 0.01% | -33.3% |
| Q3 2018 | $86,047,000 | +33.5% | 313,480 | +0.7% | 0.02% | +31.2% |
| Q2 2018 | $64,460,000 | +26.2% | 311,147 | +0.6% | 0.02% | +23.1% |
| Q1 2018 | $51,064,000 | +19.7% | 309,186 | -0.8% | 0.01% | +18.2% |
| Q4 2017 | $42,666,000 | -0.5% | 311,584 | -1.1% | 0.01% | 0.0% |
| Q3 2017 | $42,877,000 | +11.6% | 314,933 | -0.5% | 0.01% | 0.0% |
| Q2 2017 | $38,435,000 | +23.3% | 316,587 | +7.5% | 0.01% | +22.2% |
| Q1 2017 | $31,181,000 | +4.7% | 294,605 | +0.5% | 0.01% | 0.0% |
| Q4 2016 | $29,786,000 | -32.8% | 293,141 | -32.5% | 0.01% | -35.7% |
| Q3 2016 | $44,330,000 | -10.5% | 434,356 | +4.6% | 0.01% | -12.5% |
| Q2 2016 | $49,539,000 | +17.9% | 415,346 | -1.9% | 0.02% | +14.3% |
| Q1 2016 | $42,006,000 | -12.2% | 423,189 | -4.1% | 0.01% | -12.5% |
| Q4 2015 | $47,858,000 | +33.5% | 441,421 | +5.5% | 0.02% | +33.3% |
| Q3 2015 | $35,847,000 | +38.1% | 418,531 | +62.7% | 0.01% | +50.0% |
| Q2 2015 | $25,963,000 | -21.8% | 257,317 | -40.3% | 0.01% | -20.0% |
| Q1 2015 | $33,208,000 | +48.8% | 430,657 | +2.6% | 0.01% | +42.9% |
| Q4 2014 | $22,324,000 | +14.7% | 419,554 | +1.3% | 0.01% | +16.7% |
| Q3 2014 | $19,463,000 | +24.6% | 414,191 | +65.1% | 0.01% | +20.0% |
| Q2 2014 | $15,624,000 | -37.0% | 250,819 | -32.0% | 0.01% | -37.5% |
| Q1 2014 | $24,801,000 | +62.5% | 368,689 | +27.1% | 0.01% | +60.0% |
| Q4 2013 | $15,261,000 | +23.8% | 290,146 | +1.9% | 0.01% | +25.0% |
| Q3 2013 | $12,323,000 | +13.5% | 284,742 | -2.0% | 0.00% | 0.0% |
| Q2 2013 | $10,862,000 | – | 290,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |